Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ana Paric"'
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 803-810 (2023)
Colorectal cancer (CRC) is the third leading cause of mortality worldwide. The Food and Drug Administration recently designated pembrolizumab, an immune checkpoint inhibitor (ICI) against a programmed death-1 receptor, as a breakthrough drug for the
Externí odkaz:
https://doaj.org/article/3c58e900962d4f1e82ca5951169b079d
Autor:
Krešimir Tomić, Ana Paric, Gordana Berić Jozić, Eduard Vrdoljak, Dragan Soldo, Inga Marijanović, Ivan Lasić
Publikováno v:
Wiener klinische Wochenschrift. 133:1155-1161
BACKGROUND Given the lack of primary and secondary prevention programs and cancer awareness in general, cervical cancer remains one of the main causes of cancer-related death in developing countries, such as Bosnia and Herzegovina. Optimization of co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5461c1a88358c71239f338ef35b4dce
https://doi.org/10.1007/s00508-021-01958-0
https://doi.org/10.1007/s00508-021-01958-0
Publikováno v:
Acta Medica Academica, Vol 45, Iss 2, Pp 104-120 (2016)
Objective . To investigate cancer pain management and evaluate factors that could be addressed and lead to potential improvement of pain therapy. Materials and methods . Two hundred patients with metastatic cancer pain at the Department of Oncology,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b81b5744684a593f455f9fe124b9c602
https://pubmed.ncbi.nlm.nih.gov/28000486
https://pubmed.ncbi.nlm.nih.gov/28000486